Montepio, Melanie R.
HRN: 28-56-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
METRONIDAZOLE 500MG (TAB)
02/18/2026
02/21/2026
ORAL
500mg
TID
Intestinal Amebiasis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines